The Clorox Company (NYSE:CLX) previous close was $180.68 while the outstanding shares total 125.61M. The firm has a beta of 0.18, a 12-month trailing P/E ratio of 25.36, and a growth ratio of 7.81. CLX’s shares traded higher over the last trading session, gaining 0.54% on 05/18/21. The shares fell to a low of $179.77 before closing at $181.66. Intraday shares traded counted 1.1 million, which was 25.44% higher than its 30-day average trading volume of 1.48M. The stock’s Relative Strength Index (RSI) is 41.75, with weekly volatility at 1.82% and ATR at 3.73. The CLX stock’s 52-week price range has touched low of $176.73 and a $239.87 high.
Investors have identified the Household & Personal Products company The Clorox Company as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $22.76 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
The Clorox Company (CLX) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. For CLX, the company has in raw cash 492.0 million on their books with 300.0 million currently as liabilities. How the trend is over time is what investors should be concerned about. The company has a healthy balance sheet as their debt profile has been on an incline. In terms of their assets, the company currently has 1.96 billion total, with 1.82 billion as their total liabilities.
Having a look at the company’s valuation, the company is expected to record 7.66 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on CLX sounds very interesting.
Is the stock of CLX attractive?
In related news, EVP – Chief Operating Officer, Reynolds Eric H sold 1,015 shares of the company’s stock in a transaction that recorded on Apr 05. The sale was performed at an average price of 193.04, for a total value of 195,931. As the sale deal closes, the EVP – Chief Operating Officer, Reynolds Eric H now sold 1,222 shares of the company’s stock, valued at 221,353. Also, EVP – Chief Operating Officer, Reynolds Eric H sold 3,147 shares of the company’s stock in a deal that was recorded on Jan 25. The shares were price at an average price of 214.07 per share, with a total market value of 673,685. Following this completion of acquisition, the EVP – Chief Financial Officer, Jacobsen Kevin B now holds 35,176 shares of the company’s stock, valued at 7,562,840. In the last 6 months, insiders have changed their ownership in shares of company stock by 0.20%.
2 out of 17 analysts covering the stock have rated it a Buy, while 8 have maintained a Hold recommendation on The Clorox Company. 4 analysts has assigned a Sell rating on the CLX stock. The 12-month mean consensus price target for the company’s shares has been set at $192.46.